COMPARISON TOOL
Compare peptides
Half-life, dosing, mechanism, status — side by side. Select up to four compounds, or start from a preset.
CagriSemaMax 4 peptides
| Property | CagriSema |
|---|---|
| Category | GLP-1 |
| Type | Peptide blend |
| Mechanism | Cagrilintide (amylin) + semaglutide (GLP-1) |
| Status | Phase 3 |
| Dosing range | 0.25–2.4 mg of each, weekly |
| Frequency | Once weekly |
| Half-life | ~7 days |
| Route | Subcutaneous |
| Onset | 1–4 weeks for appetite reduction |
| Studied for |
|
| Key risks |
|
| Storage | Refrigerated (2–8 °C); use within the pharmacy beyond-use date |
| Available at G1 | Not currently carried. Ask a provider |
| Tools | Dosage calculator → |
PROPERTY COMPARISON · RADAR
Profile shape
TYPICAL DOSE RANGES
Dose envelope
CagriSema500 mcg – 4.8 mg
Typical per-dose range on a logarithmic scale. Your provider sets your dose.
For educational purposes only. Consult a licensed provider before starting any peptide protocol.